SCHEMBL17034994

SCHEMBL17034994

c1ccc(-c2nc3ccccc3c3c2cc(-c2ccc(-c4cccc5c4oc4ccccc45)cc2)c2ccccc23)cc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 2/20 0.48
GGPS1 O95749 1/20 0.39
PRKDC P78527 4/20 0.39
MEN1 O00255 2/20 0.39
KMT2A Q03164 2/20 0.39
CSF1R P07333 1/20 0.39
PDGFRB P09619 1/20 0.39
MAPT P10636 1/20 0.39
KIT P10721 1/20 0.39
FLT3 P36888 1/20 0.39
HDAC6 Q9UBN7 1/20 0.39
JAK2 O60674 1/20 0.37
JAK1 P23458 1/20 0.37
TYK2 P29597 1/20 0.37
PTGES2 Q9H7Z7 1/20 0.37
CDC14B O60729 1/20 0.36
CDC14A Q9UNH5 1/20 0.36
PIK3CD O00329 2/20 0.35
PIK3CB P42338 2/20 0.35
ADORA2A P29274 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17034995 0.95 ALOX5 (0.48) ALOX5GGPS1PRKDCMEN1KMT2A
SCHEMBL18842528 0.91 MEN1 (0.39) ALOX5PRKDCMEN1KMT2ACSF1R
SCHEMBL17034992 0.89 ALOX5 (0.41) ALOX5GGPS1PRKDCMEN1KMT2A
SCHEMBL20864381 0.87 ALOX5 (0.44) ALOX5GGPS1PRKDCMEN1KMT2A
SCHEMBL17914734 0.86 ALOX5 (0.48) ALOX5GGPS1PRKDCMEN1KMT2A
SCHEMBL18842499 0.86 MEN1 (0.36) ALOX5MEN1KMT2ACSF1RPDGFRB
SCHEMBL22483263 0.86 ALOX5 (0.52) ALOX5GGPS1PRKDCMEN1KMT2A
SCHEMBL18842532 0.86 ALOX5 (0.38) ALOX5GGPS1PRKDCMEN1KMT2A
SCHEMBL18842490 0.86 ALOX5 (0.38) ALOX5GGPS1PRKDCMEN1KMT2A
SCHEMBL20864812 0.85 ALOX5 (0.41) ALOX5GGPS1PRKDCMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9871208-B2 Condensed cyclic compound and organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2018-01-16 US disclosed
US-9871208-B2 Condensed cyclic compound and organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2018-01-16 US disclosed
US-20150243908-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2015-08-27 US disclosed
US-20150243908-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2015-08-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150243908-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, CCNE2 ALOX5 2058/4885GGPS1 329/4885PRKDC 4484/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.